Diabetic Retinopathy: Increasing Disease Prevalence

Then, Now, and Tomorrow: Evolving the Management of Diabetic: Retinopathy and the Role of the Optometrist
0.5 COPE
Launch Date:
September 20, 2019
Expiration Date:
August 19, 2021

Primary Audience:


Relevant Terms:

Diabetic macular edema, Macular edema, Diabetic retinopathy, Retinopathy

Ehsan Rahimy, MD

Surgical and Medical Vitreoretinal Specialist
Palo Alto Medical Foundation 
Palo Alto, Calif.

1. Discuss the increasing prevalence of diabetes and diabetic retinopathy.
2. Identify which patients need to be screened earlier based on their disease state.

Evolve is an approved COPE Administrator

This course is COPE approved for .5 hours of CE Credit for Optometrists.

COPE Course ID # 64436-PS

COPE Activity ID #117992


Faculty and Disclosures

Ehsan Rahimy, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, plc, Genentech, Google, and Regeneron Pharmaceuticals. Speakers Bureau: Regeneron Pharmaceuticals.
Editorial Support Disclosures
Erin K. Fletcher, MIT, director of compliance and education; Susan Gallagher-Pecha, director of client services and project management; Cassandra Richards, director of education development, Evolve have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Grantor Statement

This educational activity is supported by a medical educational grant from Regeneron Pharmaceuticals, Inc., and Carl Zeiss Meditec, Inc.

Off-Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals, or Carl Zeiss Meditec.



Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above